Contribution of metformin therapy with extended release formulas
Authors:
Andrej Dukát; Juraj Payer; Milan Kriška; Ján Gajdošík; Fedor Šimko
Authors‘ workplace:
V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
1; Ústav farmakológie a lekárskej farmakológie LF UK v Bratislave
2; Neštátna ambulancia pre dospelých v Nových Zámkoch
3; Ústav patologickej fyziológie LF UK v Bratislave
4
Published in:
Forum Diab 2021; 10(1): 25-27
Category:
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
Most read in this issue
- De-intensification of treatment in patient with diabetes mellitus could be beneficial
- Second generation basal insulin analogues in clinical trials using continuous monitoring of glucose levels
- Osteoporosis in endocrinopathies
- Population differences in the prevalence of diabetes mellitus, its risk factors and complications